GTBP
GT Biopharma Inc
NASDAQ: GTBP · HEALTHCARE · BIOTECHNOLOGY
$0.31
+13.31% today
Updated 2026-04-30
Market cap
$8.83M
P/E ratio
—
P/S ratio
204.96x
EPS (TTM)
$-6.68
Dividend yield
—
52W range
$0 – $4
Volume
0.7M
GT Biopharma Inc (GTBP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-671000.00 | $-270000.00 | $-169000.00 | $-937000.00 | $-1.53M | $-963000.00 | $-987000.00 | $-442000.00 | $-1.75M | $-4.66M | $-1.93M | $-5.43M | $-10.68M | $-3.66M | $-7.26M | $-15.61M | $-15.22M | $-8.85M | $-12.90M | $-12.91M |
| Capital expenditures | $108000.00 | $97000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2000.00 | $0.00 | $6000.00 | $1000.00 | $4000.00 | $4000.00 | $36000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.84M | $96000.00 | — | $146000.00 | $149000.00 | $307000.00 | — | — | $2.63M | $3.76M | $6.59M | $130.12M | $9.70M | $5.31M | $269000.00 | $33.93M | $7.65M | $2.20M | $230000.00 | $432000.00 |
| Free cash flow | $-779000.00 | $-367000.00 | $-169000.00 | $-937000.00 | $-1.53M | $-963000.00 | $-989000.00 | $-442000.00 | $-1.75M | $-4.66M | $-1.93M | $-5.43M | $-10.71M | $-3.66M | $-7.26M | $-15.61M | $-15.22M | $-8.85M | $-12.90M | $-12.91M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $229000.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $5.27M | — | — | — | — | — |